UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018721 |
|---|---|
| Receipt number | R000021660 |
| Scientific Title | Pharmacokinetic, pharmacodynamic and biomarker study of phase I/II study of olaparib in combination with eribulin mesylate for patients with recurrent or metastatic triple-negative-type breast cancer |
| Date of disclosure of the study information | 2015/08/21 |
| Last modified on | 2021/08/23 10:27:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/08/19 11:33:04 | ||
| 2 | Update | 2015/08/21 11:38:52 | Acronym |
|
| 3 | Update | 2015/08/21 11:40:07 | Other related information Other related information |
|
| 4 | Update | 2016/05/17 21:20:03 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 5 | Update | 2017/03/25 09:37:29 | Recruitment status |
|
| 6 | Update | 2021/08/23 10:27:08 | Recruitment status Date of IRB Last follow-up date |
